thelin
pfizer ltd. - sitaxentan-natrium - hypertension, lunge - antihypertensiva, - behandling af patienter med pulmonal arteriel hypertension (pah) klassificeret som who funktionsklasse iii, for at forbedre træningskapaciteten. effektivitet er blevet vist ved primær lunghypertension og i lungehypertension associeret med bindevævssygdom.
tekturna
novartis europharm ltd. - aliskiren - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension.
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
lopid 600 mg filmovertrukne tabletter
2care4 aps - gemfibrozil - filmovertrukne tabletter - 600 mg
lopid 600 mg filmovertrukne tabletter
orifarm a/s - gemfibrozil - filmovertrukne tabletter - 600 mg
lopid 300 mg kapsler, hårde
pfizer aps - gemfibrozil - kapsler, hårde - 300 mg
lopid 300 mg kapsler, h?rde
2care4 aps - gemfibrozil - kapsler, hårde - 300 mg
purimmun 50 mg tabletter
2care4 generics aps - mercaptopurin - tabletter - 50 mg
lopid 600 mg filmovertrukne tabletter
nordic prime aps - gemfibrozil - filmovertrukne tabletter - 600 mg
lopid 300 mg kapsler, h?rde
orifarm a/s - gemfibrozil - kapsler, hårde - 300 mg